BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31469641)

  • 1. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
    Raza SJ; Miller C; May A; Davaro F; Siddiqui SA; Hamilton Z
    Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
    Zhai TS; Jin L; Zhou Z; Liu X; Liu H; Chen W; Lu JY; Yao XD; Feng LM; Ye L
    BMC Cancer; 2019 Dec; 19(1):1207. PubMed ID: 31830927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of lymphadenectomy in upper tract urothelial carcinoma.
    Weight CJ; Gettman MT
    Urol Clin North Am; 2011 Nov; 38(4):429-37, vi. PubMed ID: 22045174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.
    Winer AG; Vertosick EA; Ghanaat M; Corradi RB; Carlsson S; Sjoberg DD; Sankin AI; Sfakianos JP; Cha EK; Dalbagni G; Coleman JA
    Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
    Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
    Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
    Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
    World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.
    Mason RJ; Kassouf W; Bell DG; Lacombe L; Kapoor A; Jacobsen N; Fairey A; Izawa J; Black P; Tanguay S; Chin J; So A; Lattouf JB; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Fradet Y; Rendon RA
    Urology; 2012 Apr; 79(4):840-5. PubMed ID: 22365453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.
    Zareba P; Rosenzweig B; Winer AG; Coleman JA
    Cancer; 2017 May; 123(10):1741-1750. PubMed ID: 28152158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical templates of lymph node dissection for upper tract urothelial carcinoma: a systematic review of the literature.
    Campi R; Minervini A; Mari A; Hatzichristodoulou G; Sessa F; Lapini A; Sessa M; Gschwend JE; Serni S; Roscigno M; Carini M
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):235-246. PubMed ID: 28103449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
    Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
    World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
    Lee EK; Herr HW; Dickstein RJ; Kassouf W; Munsell MF; Grossman HB; Dinney CP; Kamat AM
    BJU Int; 2012 Dec; 110(11 Pt B):E590-5. PubMed ID: 22758775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract.
    Roscigno M; Cozzarini C; Bertini R; Scattoni V; Freschi M; Da Pozzo LF; Briganti A; Gallina A; Capitanio U; Colombo R; Giorgio G; Montorsi F; Rigatti P
    Eur Urol; 2008 Apr; 53(4):794-802. PubMed ID: 18207313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
    Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K
    Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.